Quantbot Technologies LP Has $138,000 Stake in Colgate-Palmolive Company $CL

Quantbot Technologies LP lessened its position in Colgate-Palmolive Company (NYSE:CL) by 95.5% in the second quarter, Holdings Channel.com reports. The firm owned 1,504 shares of the company’s stock after selling 32,067 shares during the quarter. Quantbot Technologies LP’s holdings in Colgate-Palmolive were worth $138,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Emerald Investment Advisers LLC boosted its stake in shares of Colgate-Palmolive by 100.9% during the second quarter. Emerald Investment Advisers LLC now owns 17,056 shares of the company’s stock valued at $1,564,000 after purchasing an additional 8,567 shares in the last quarter. Landscape Capital Management L.L.C. bought a new position in Colgate-Palmolive in the 2nd quarter valued at approximately $10,022,000. Korea Investment CORP raised its holdings in Colgate-Palmolive by 54.1% in the 2nd quarter. Korea Investment CORP now owns 742,483 shares of the company’s stock valued at $68,071,000 after buying an additional 260,573 shares during the last quarter. EP Wealth Advisors LLC boosted its position in Colgate-Palmolive by 19.3% during the 2nd quarter. EP Wealth Advisors LLC now owns 427,686 shares of the company’s stock worth $39,210,000 after buying an additional 69,195 shares during the period. Finally, Ieq Capital LLC grew its holdings in Colgate-Palmolive by 176.1% during the 2nd quarter. Ieq Capital LLC now owns 10,650 shares of the company’s stock worth $976,000 after acquiring an additional 6,793 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director John T. Cahill sold 4,170 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This trade represents a 12.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Noel R. Wallace sold 161,021 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. This represents a 30.77% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is owned by corporate insiders.

Colgate-Palmolive Stock Performance

Shares of CL opened at $90.75 on Monday. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The stock has a market capitalization of $72.34 billion, a P/E ratio of 36.01, a price-to-earnings-growth ratio of 4.24 and a beta of 0.33. The firm’s fifty day simple moving average is $92.02 and its two-hundred day simple moving average is $90.03. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.04. The firm had revenue of $5.36 billion during the quarter, compared to the consensus estimate of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The business’s revenue was up 4.9% compared to the same quarter last year. During the same period last year, the business posted $0.92 EPS. As a group, analysts predict that Colgate-Palmolive Company will post 3.86 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, July 20th were paid a dividend of $0.53 per share. The ex-dividend date of this dividend was Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a research note on Monday, August 3rd. Barclays boosted their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Piper Sandler raised their target price on Colgate-Palmolive from $92.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. TD Cowen upped their target price on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a report on Monday, August 3rd. Finally, Citigroup increased their target price on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Twelve equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $99.00.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.